Related Experiment Video
Updated: Jul 5, 2025
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Angiopoietin as a Novel Prognostic Marker in Kidney Disease
Abdullah B Yildiz1, Sidar Copur1, Cem Tanriover1
1Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
Insights
Angiopoietin-2 may predict acute kidney injury (AKI) and chronic kidney disease (CKD) progression. Higher angiopoietin-2 levels are found in AKI patients, suggesting its clinical importance.
Area of Science:
- Nephrology
- Vascular Biology
- Biomarker Discovery
Background:
- Renal injury significantly contributes to morbidity and mortality.
- Current indicators for chronic kidney disease (CKD) and acute kidney injury (AKI) are limited.
- Angiopoietins, vascular growth factors, are involved in endothelial function and inflammation, and show potential as AKI markers.
Purpose of the Study:
- To review the role of angiopoietins in kidney injury.
- To explore angiopoietin-2 as a potential predictor for AKI and CKD progression.
Main Methods:
- Literature review examining the relationship between kidney injury and angiopoietins.
- Analysis of angiopoietin levels in AKI patients.
Main Results:
- AKI patients exhibit elevated angiopoietin-2 levels.
- A higher angiopoietin-1 to angiopoietin-2 ratio may correlate with reduced risk of CKD progression.
- Angiopoietin-2 is proposed as a significant predictor for AKI in clinical settings.
Conclusions:
- Further large-scale randomized clinical trials are necessary.
- Understanding the full significance and clinical implications of angiopoietin-2 requires more research.
Introduction:
Renal injury is among the leading causes of morbidity and mortality; however, there are no reliable indicators for determining the likelihood of developing chronic kidney disease (CKD), CKD progression, or AKI events. Vascular growth factors called angiopoietins have a role in endothelial function, vascular remodeling, tissue stabilization, and inflammation and have been implicated as prognostic and predictive markers in AKI.
Methods:
Although the exact mechanism of the relationship between kidney injury and angiopoietins is unknown, this review demonstrates that AKI patients have higher angiopoietin-2 levels and that higher angiopoietin-1 to angiopoietin-2 ratio may potentially be linked with a reduced risk of the CKD progression.
Results:
This review therefore emphasizes the importance of angiopoietin-2 and proposes that it could be an important predictor of AKI in clinical settings.
Conclusion:
There is a need for further large-scale randomized clinical trials in order to have a better understanding of the significance of angiopoietin-2 and for the determination of its potential clinical implications.
